Indications and uses
For treatment of tinea versicolor, seborrheic dermatitis of scalp and treatment of dandruff.
For treatment of tinea versicolor, seborrheic dermatitis of scalp and treatment of dandruff.
See Application Instructions .
SHAKE WELL BEFORE USING.
Keep tightly capped. SHAKE WELL BEFORE USING. Product may damage jewelry; remove jewelry before use.
For treatment of tinea versicolor:
For treatment of dandruff and seborrheic dermatitis of the scalp.
For External Use Only. Do not use on broken skin or inflamed areas. If allergic reactions occur, discontinue use. Avoid getting shampoo in eyes or in contact with genital area as it may cause irritation and burning.
FOR EXTERNAL USE ONLY. WARNING: KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Store at controlled room temperature, (15 - 30) °C ((59 - 86) °F) [see USP].
Selenium sulfide appears to have a cytostatic effect on cells of the epidermis and follicular epithelium, reducing corneocyte production.
For treatment of tinea versicolor, seborrheic dermatitis of scalp and treatment of dandruff.
Not to be used by patients allergic to any of its ingredients.
General:
Not to be used when acute inflammation or exudation is present as increased absorption may occur.
Information for Patients:
See Warnings and Precautions section under Application Instructions.
Carcinogenesis:
Dermal application of 25% and 50% solutions of 2.5% selenium sulfide lotion on mice over an 88 week period, indicated no carcinogenic effects.
Pregnancy:
WHEN USED ON BODY SURFACES FOR THE TREATMENT OF TINEA VERSICOLOR, SELENIUM SULFIDE LOTION, USP 2.5% IS CLASSIFIED AS PREGNANCY CATEGORY C. Animal reproduction studies have not been conducted with selenium sulfide. It is also not known whether selenium sulfide can cause fetal harm when applied to body surfaces of a pregnant woman or can affect reproduction capacity. Under ordinary circumstances selenium sulfide should not be used for the treatment of tinea versicolor in pregnant women.
Pediatric Use:
Safety and effectiveness in infants have not been established.
In decreasing order of severity: skin irritation; occasional reports of increase in normal hair loss; discoloration of hair (can be avoided or minimized by thorough rinsing of hair after treatment). As with other shampoos, oiliness or dryness of hair and scalp may occur.
No documented reports of serious toxicity in humans resulting from acute ingestion of selenium sulfide, however, acute toxicity studies in animals suggest that ingestion of large amounts could result in potential human toxicity. Evacuation of the stomach contents should be considered in cases of acute oral ingestion.
Apply to affected areas and lather with a small amount of water. Allow product to remain on skin for 10 minutes, then rinse the body thoroughly. Repeat procedure once a day for 7 days.
Usually two applications each week for two weeks will afford control. After this, the lotion may be used at less frequent intervals – weekly, every two weeks, or every 3 or 4 weeks in some cases. Should not be applied more frequently than required to maintain control.
Selenium Sulfide Lotion, USP 2.5% is supplied in 4 fl oz (118 mL) bottles.
PROTECT FROM HEAT. FOR EXTERNAL USE ONLY.
KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.
Rx Only
Product No.: 8528
A50-8528-04
REV. 01-05
Manufactured By:
Morton Grove Pharmaceuticals, Inc.
Morton Grove, IL 60053
MGP
NDC 60432-528-04
6506-00-299-8671
SELENIUM SULFIDE
LOTION, USP 2.5%
DESCRIPTION: Selenium Sulfide Lotion, USP 2.5% is a
liquid antiseborrheic, antifungal preparation for topical
application, containing selenium sulfide 2.5% w/v in
aqueous suspension. Also contains: Amphoteric-2;
Bentonite, NF; Captan; Citric Acid, USP; D&C Yellow
#10; Ethylene Glycol Monostearate; Glyceryl
Monoricinoleate; Lauric Diethanolamide; Perfume;
Purified Water, USP; Sodium Lauryl Sulfate; Sodium
Phosphate Monobasic, USP and Titanium Dioxide, USP.
Additional prescribing information inside.
WARNING: KEEP OUT OF THE REACH OF CHILDREN.
FOR EXTERNAL USE ONLY.
Store at controlled room temperature, (15 - 30) °C
((59 - 86) °F) [see USP].
Rx Only
NET: 4 fl oz (118 mL)
Manufactured By:
Morton Grove
Pharmaceuticals, Inc.
Morton Grove, IL 60053
DO NOT USE IF INNER FOIL
SEAL PRINTED "SEALED
FOR YOUR PROTECTION"
IS BROKEN OR MISSING.

MGP
NDC 60432-528-05
Selenium Sulfide Lotion, USP 2.5%
FOR EXTERNAL USE ONLY
Rx Only
Net: 4 fl oz (118 mL)

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 60432-528-04 | 2025-12-12 | C162847 | 48780-1 | f386c649-a94b-0266-e053-dadaa90a7c1a | SELENIUM SULFIDE LOTION, USP 2.5% |
| 60432-528-05 | 2025-12-12 | C162847 | 48780-1 | f386c649-a94b-0266-e053-dadaa90a7c1a | SELENIUM SULFIDE LOTION, USP 2.5% |
| 60432-528-04 | 2023-01-30 | C162847 | 48780-1 | f386c649-a94b-0266-e053-dadaa90a7c1a | SELENIUM SULFIDE LOTION, USP 2.5% |
| 60432-528-05 | 2023-01-30 | C162847 | 48780-1 | f386c649-a94b-0266-e053-dadaa90a7c1a | SELENIUM SULFIDE LOTION, USP 2.5% |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60432-528-04 | ML - Milliliter | 60432-528 | 1ef92146-113c-46c0-8953-fdf2f4e5cbfd | 1 | 2013-02-13 |
| 60432-528-05 | ML - Milliliter | 60432-528 | a868770a-dea8-4884-9dfb-5ed30aaf2ac0 | 1 | 2019-04-11 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Selenium Sulfide | ACTIVE INGREDIENT | Z69D9E381Q | 1 | |
| Selenium Sulfide | ACTIVE MOIETY | Z69D9E381Q | 1 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 1 | |
| BENTONITE | INACTIVE INGREDIENT | A3N5ZCN45C | 1 | |
| CAPTAN | INACTIVE INGREDIENT | EOL5G26Q9F | 1 | |
| CASTOR OIL | INACTIVE INGREDIENT | D5340Y2I9G | 1 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | 1 | |
| DISODIUM COCOAMPHODIACETATE | INACTIVE INGREDIENT | 18L9G3U51M | 1 | |
| GLYCOL STEARATE | INACTIVE INGREDIENT | 0324G66D0E | 1 | |
| LAURIC DIETHANOLAMIDE | INACTIVE INGREDIENT | I29I2VHG38 | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | 1 | |
| SODIUM PHOSPHATE, MONOBASIC | INACTIVE INGREDIENT | 3980JIH2SW | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 60432-528 | 60432-528-04, 60432-528-05 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | SOLUTION / RECTAL | NA | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | POWDER, FOR SUSPENSION / ORAL | 64 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SHAMPOO, SUSPENSION / TOPICAL | 3.25 %w/v | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / RESPIRATORY (INHALATION) | 2 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | CAPSULE, COATED PELLETS / ORAL | 1 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | CREAM / TOPICAL | 214 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | CAPSULE / ORAL | 20 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / ORAL | 3900 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | CREAM / VAGINAL | 12 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CREAM / TOPICAL | 80 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY / TOPICAL | 0.01 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE / ORAL | 55 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | EMULSION / OPHTHALMIC | 32 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | INSERT, EXTENDED RELEASE / OPHTHALMIC | 0.4 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, COATED / ORAL | 0.9 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 99 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRACARDIAC | 25 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET / BUCCAL | 30 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, SOLUBLE / BUCCAL | 11 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, CHEWABLE / ORAL | 4 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | CAPSULE, EXTENDED RELEASE / ORAL | 3 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET, FILM COATED / ORAL | 120 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, SOLUBLE / ORAL | 2 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | PASTE / DENTAL | NA | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, FILM COATED / ORAL | 15.29 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | LOTION / TOPICAL | NA | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAVENOUS | 772 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | GUM, CHEWING / ORAL | 2 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, FOR SUSPENSION / ORAL | 264 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | CAPSULE / ORAL | ADJ PH | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / ORAL | 46 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / BUCCAL | 5.18 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EFFERVESCENT / ORAL | 840 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SUSPENSION / ORAL | 65 mg/5ml | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | OIL / TOPICAL | 2 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE / DENTAL | 0.5 %w/w | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, DELAYED RELEASE / ORAL | 199 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | SHAMPOO / TOPICAL | 65 %w/w | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / OPHTHALMIC | 0.09 %w/v | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | CAPSULE, DELAYED RELEASE / ORAL | 1 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | SUSPENSION, EXTENDED RELEASE / ORAL | 1 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | LOTION / TOPICAL | 111 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INFILTRATION | 0.02 %w/v | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / ORAL | 400 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | CAPSULE, LIQUID FILLED / ORAL | 1.51 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | TABLET / ORAL | 355 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | OINTMENT / TOPICAL | 5 %w/w | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | LOTION / TOPICAL | NA | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, CHEWABLE / ORAL | 6 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, LIQUID FILLED / ORAL | 12 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | GEL / VAGINAL | 0.2 %w/w | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | POWDER / TOPICAL | 0.67 mg/mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / TOPICAL | 4.35 %w/v | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | GEL / NASAL | 429 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EXTENDED RELEASE / ORAL | 312 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | SOAP / TOPICAL | 1.4 %w/w |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A088228-001 | SELENIUM SULFIDE | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | AT | 1983-09-01 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | AT | 1983-09-01 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | AT | 1983-09-01 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | AT | 1983-09-01 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | AT | 1983-09-01 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | AT | 1983-09-01 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | AT | 1983-09-01 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | AT | 1983-09-01 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | AT | 1983-09-01 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | AT | 1983-09-01 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | AT | 1983-09-01 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | AT | 1983-09-01 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | AT | 1983-09-01 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A088228-001 | SELENIUM SULFIDE | 2.5% | LOTION/SHAMPOO / TOPICAL | 1983-09-01 | f41ea6bd6efb… |
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A088228-001 | AT | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A088228-001 | AT | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A088228-001 | AT | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A088228-001 | AT | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A088228-001 | AT | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A088228-001 | AT | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A088228-001 | AT | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A088228-001 | AT | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A088228-001 | AT | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A088228-001 | AT | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A088228-001 | AT | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A088228-001 | AT | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A088228-001 | AT | 1 | ea99ee380514… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 45bc9004-5e20-da30-e063-6394a90afab9 | d6e65fd4-dcbd-461e-b7b5-d9a7eb799489 | 2025-12-12 | Warnings, Adverse reactions | d6e65fd4-dcbd-461e-b7b5-d9a7eb799489 |
Adverse event summaries are temporarily unavailable. Other product information remains available.